Healthcare >> CEO Interviews >> March 15, 1999

Steven Gillis – Corixa Corporation (crxa)

DR. STEVEN GILLIS is President & CEO of Corixa Corporation. Education: 1971-75 B.A. (Cum Laude) Highest Honors in Biology William's College Williamstown, Massachusetts; 1975-78 Ph.D., Biological Sciences, Specialization: Cellular and Tumor Immunology, Dartmouth College Hanover, New Hampshire. Honors: 1975 Phi Beta Kappa; 1975 Sigma Xi, Associate Member; 1976 Conant-Harrington Prize for Outstanding Research in Biology; 1982 New York Academy of Science; 1983 International Immunopharmacology Award. Positions Held: 1994 President, Chief Executive Officer Corixa Corporation, Seattle, WA; 1990-94 President, CEO, Immunex Research and Development Corporation, Seattle, WA; 1990-97 Adjunct Professor, University of Washington, Department of Immunology, Seattle, WA; 1988-90 President, Chief Operating Officer, Immunex Research and Development Corporation, Seattle, WA; 1982- Executive Vice President, Director of Research and Development, Immunex Corporation; 1982-90 Adjunct Associate Professor, University of Washington, Department of Microbiology and Immunology, Seattle, WA; 1982- 90 Affiliate Investigator, Basic Immunology Program, Fred Hutchinson Cancer Research Center, Seattle, WA; 1980-83 Assistant Professor, Department of Microbiology and Immunology, University of Washington, Seattle, WA; 1980-82 Assistant Member, Basic Immunology Program, Fred Hutchinson Cancer Research Center, Seattle, WA; 1979-80 Associate Researcher, Memorial Sloan-Kettering Cancer Center, Laboratory of Development Hematopoiesis, New York, NY; 1978-79 Research Associate, Hematology Research, Dartmouth Medical School, Hanover, NH; 1977-78 Lecturer in Biology, Department of Biological Sciences, Dartmouth College, Hanover, NH; 1976-78 Research Fellow, Department of Biological Sciences, Norris Cotton Cancer Center, Hanover, NH and 1975-76 Teaching Fellow, Department of Biological Sciences, Dartmouth College, Hanover, NH. Profile
TWST: Could you begin by giving us a background summary on the company,

enough information to put us into context as what you see as your

business and what you see as your company today?

Dr.